MedTrace Logo

Characterization by Clinimetric Indicators of Chronic Low Back Pain Subjects Versus Healed Patients

NCT03635242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-03-17

No results posted yet for this study

Summary

Pretending with the use of accelerometers and pressure platform, determine indicators that are useful to therapists to assess postural control and balance, to subsequently allow to evaluate the effect of therapeutic interventions through therapeutic exercise of motor control in patients with chronic low back pain .

Conditions

  • Chronic Low Back Pain
  • Postural Low Back Pain

Interventions

OTHER

Control. no therapeutic program

The control group continued to perform their daily activities without changing any habit. Group of healthy subjects Assessment of postural control through accelerometry and pressure platform

OTHER

Experimental. Therapeutic program

People with chronic back pain of at least 3 months duration, to whom the therapeutic exercise of motor control and pain education based on neuroscience will be applied 2 days a week for 2 months. Prior to the intervention, a postural control assessment will be made by accelerometry and pressure platform

Sponsors & Collaborators

  • University of Extremadura

    lead OTHER

Principal Investigators

  • Luis LE Espejo-Antúnez, PhD · Universidad de Extremadura. Facultad de Medicina (Badajoz). Spain

  • Mª Dolores MD Apolo-Arenas, PhD · Universidad de Extremadura. Facultad de Medicina (Badajoz). Spain

  • Alejandro Caña-Pino, PT,MSc · Universidad de Extremadura. Facultad de Medicina (Badajoz). Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-08
Primary Completion
2018-08-08
Completion
2018-10-09

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03635242 on ClinicalTrials.gov